CDT Equity, Inc. (CDT)
3.24
-0.29
(-8.22%)
USD |
NASDAQ |
Apr 17, 12:17
CDT Equity EPS Diluted (Quarterly) : -329.03 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | -1.155 |
| Liminatus Pharma, Inc. | -0.3018 |
| Oruka Therapeutics, Inc. | -0.5436 |
| Maze Therapeutics, Inc. | -0.7007 |
| MapLight Therapeutics, Inc. | -1.807 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.118M |
| Total Expenses (Quarterly) | 7.118M |
| Enterprise Value | 14.20M |
| Earnings Yield | -204.7K% |
| Normalized Earnings Yield | -266854.7 |